Date of Presentation
5-5-2022 12:00 AM
College
School of Osteopathic Medicine
Poster Abstract
Obsessive-compulsive disorder (OCD) occurs in about 1-3% of the pediatric population, but many do not respond to standard therapies. Riluzole, a glutamate antagonist, has shown to be an effective treatment for refractory OCD in adults, however few trials have been conducted to show the effectiveness of Riluzole in children to treat refractory OCD. The study investigates the potential use of riluzole in children to treat refractory OCD.
Keywords
Child, Riluzole, Excitatory Amino Acid Antagonists, Obsessive-Compulsive Disorder, Treatment Outcome, Glutamates
Disciplines
Chemical and Pharmacologic Phenomena | Medicine and Health Sciences | Pharmaceutical Preparations | Psychiatric and Mental Health | Psychiatry
Document Type
Poster
Included in
Chemical and Pharmacologic Phenomena Commons, Pharmaceutical Preparations Commons, Psychiatric and Mental Health Commons, Psychiatry Commons
Riluzole for Pediatric Patients with Treatment-Refractory Obsessive-Compulsive Disorder
Obsessive-compulsive disorder (OCD) occurs in about 1-3% of the pediatric population, but many do not respond to standard therapies. Riluzole, a glutamate antagonist, has shown to be an effective treatment for refractory OCD in adults, however few trials have been conducted to show the effectiveness of Riluzole in children to treat refractory OCD. The study investigates the potential use of riluzole in children to treat refractory OCD.